| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/03/2008 | WO2008079363A2 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 07/03/2008 | WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | WO2008078785A1 Klf5 suppressor and method for selecting active ingredient of the medicament |
| 07/03/2008 | WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
| 07/03/2008 | WO2008078730A1 Preparation for transnasal application |
| 07/03/2008 | WO2008078729A1 Method for improving dissolution property |
| 07/03/2008 | WO2008078728A1 Ascorbic acid-containing pharmaceutical composition |
| 07/03/2008 | WO2008078727A1 Pharmaceutical composition having improved dissolution property |
| 07/03/2008 | WO2008078726A1 Solid preparation |
| 07/03/2008 | WO2008078725A1 Thiazepine derivative |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | WO2008078588A1 Pharmaceutical agent and method for treatment or prevention of articular cartilage deformation |
| 07/03/2008 | WO2008078095A1 Treatment of macular degeneration |
| 07/03/2008 | WO2008061208A3 Arylsulfonamide compounds |
| 07/03/2008 | WO2008061208A2 Arylsulfonamide compounds |
| 07/03/2008 | WO2008054540A9 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| 07/03/2008 | WO2008052671A3 Combination therapy of substituted oxazolidinones |
| 07/03/2008 | WO2007136653A3 Use of a rar antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects |
| 07/03/2008 | US20080161907 Stent coated with a sustained-release drug delivery and method for use thereof |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161426 p53 Inhibitors and Therapeutic Use of the Same |
| 07/03/2008 | US20080161421 Tcell mediator/modulator assay based upon Tcell restricted transgenic mouse |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161391 Novel curcumin analogues and uses thereof |
| 07/03/2008 | US20080161385 Isoflavone containing plant extracts; health foods promoting estradiol secretion; osteoporosis prevention, improving fat metabolism |
| 07/03/2008 | US20080161380 Amino acid composition |
| 07/03/2008 | US20080161374 Pyrazole compounds and uses related thereto |
| 07/03/2008 | US20080161371 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/03/2008 | US20080161362 e.g. 2-Carboxy-3-benzyloxy-6-methyl-pyran-4(1H)-one; matrix metalloproteinase inhibitors, histone deacetylase inhibitors, or anthrax lethal factor inhibitors; cell growth and division, bone growth, wound healing, embryogenesis, angiogenesis; cardiovascular disease, stroke, arthritis, tumor metastasis |
| 07/03/2008 | US20080161361 e.g. 5-methyl-1-(4-hydroxylphenyl)-2-(1H)-pyridone; pirfenidone derivatives; enhancing therapeutic efficacy of cytotoxic agent, immunosuppressant, and radiation therapy; fibrosis of the kidney or lung, radiation pneumonitis, interstitial pneumonia; cancer: lung, bone marrow, breast, colon, pancreas |
| 07/03/2008 | US20080161350 Use of quinoline derivatives with anti-integrase effect and applications thereof |
| 07/03/2008 | US20080161329 Pharmaceutical uses |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161312 Derivatives of Pyrrolo-Pyrazines Having a Kinase Inhibitory Activity and Their Biological Applications |
| 07/03/2008 | US20080161311 e.g. 2-(3,4-dichlorobenzyl)-9-hydroxy-3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,8-dione hydrochloride; AIDS, or as an anti-HIV agent; non-toxic, fewer side effects |
| 07/03/2008 | US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 07/03/2008 | US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity |
| 07/03/2008 | US20080161295 e.g. 3-(2,2-dioxido-1-phenyl-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl)-N-methylpropan-1-amine; monoamine reuptake inhibitors; antidepressant, anxiolytic, anticarcinogenic, antiinflammatory, antidiabetic agent; hyperactivity, sleep disturbance, social phobia, chronic fatigue syndrome, viral infection |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161282 Cytotoxic agents and methods of use |
| 07/03/2008 | US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 07/03/2008 | US20080161270 Angiogenesis inhibitors |
| 07/03/2008 | US20080161265 Use of lactulose in the treatment of autism |
| 07/03/2008 | US20080161260 Contacting the genomic DNA with monoclonal anti-HdU antibodies; contacting the anti-HdU antibodies bound to the HdU-containing DNA with a compound that is converted to a light-emitting product; determining the intensity of the chemiluminescent signal |
| 07/03/2008 | US20080161256 Treating Hepatitis B Virus (HBV) with Adefovir Dipivoxil in combination with a chemically synthesized double stranded nucleic acid; toxicologic properties while retaining RNAi activity |
| 07/03/2008 | US20080161243 Chimeric B-type natriuretic peptide (BNP) polypeptide for use in treatment and prevention of cardiovascular disorders |
| 07/03/2008 | US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/03/2008 | US20080161225 Isolated and purified antifungal protein MAFP1 obtained from a Monascus species and purified polynucleotide comprising a nucleotide sequence encoding antifungal protein MAFP1; useful in treating and/or controlling fungal diseases, human pathogen such as P. variotii, and plant pathogen such as H. panici |
| 07/03/2008 | US20080160617 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same, and use of the same |
| 07/03/2008 | US20080160613 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/03/2008 | US20080160576 Anti-alphabeta3 humanized monoclonal antibodies |
| 07/03/2008 | US20080160121 Identifying an epileptogenic focus of a patient; and administering a botulinum toxin; direct infusion, circumventing the blood-brain barrier |
| 07/03/2008 | US20080160119 Sesquiterpenoid Derivatives Having Adipocyte Differentiation Inhibitory Effect |
| 07/03/2008 | US20080160116 Compositions and Methods Comprising Zingiber Species |
| 07/03/2008 | US20080160094 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 07/03/2008 | US20080160081 Release-retarding matrix comprising about 40 to about 80% (by weight) hydroxypropyl methyl cellulose with a maximum apparent viscosity of about 5600 cP; benign prostatic hyperplasia, lower urinary tract symptoms, female sexual dysfunction, premature ejaculation, and primary dysmenorrheal |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160049 Tissue Vaccines and Uses Thereof |
| 07/03/2008 | US20080160048 Comprising chimeric cytomegalo virus related promoter sequence and cloning site for insertion of coding sequence in operable linkage; particle mediated gene therapy and immunization |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160026 Apo-2 ligand-anti-her-2 antibody synergism |
| 07/03/2008 | US20080160025 Glucocorticoid mixture for use in treatment and prevention of autoimmune, bone and skin disorders; tumor necrosis factor-immunoglobulin fusion for use in immnosuppressive therapy |
| 07/03/2008 | US20080160024 Inhibition of cancer metastasis |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160020 Methods For Reducing the Symptoms of Autoimmunity and Inflammation Using Binding Proteins Against Antigens Exposed on Dead or Dying Cells |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |
| 07/03/2008 | US20080160011 Alpha-synuclein kinase |
| 07/03/2008 | US20080160008 Methods and compositions for reducing amyloid beta levels |
| 07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
| 07/03/2008 | US20080160002 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 07/03/2008 | US20080159999 Cell differentiation; transfection; gene therapy; tissue engineering; Alzheimer's disease, Parkinson's disease, arthritis |
| 07/03/2008 | US20080159981 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 07/03/2008 | US20080159971 Use of dhea or precursors or metabolic derivatives thereof as a depigmenting agent |
| 07/03/2008 | CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure |
| 07/03/2008 | CA2673486A1 Substituted tetracycline compounds for treatment of inflammatory skin disorders |
| 07/03/2008 | CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939286A1 Novel peptides |
| 07/02/2008 | EP1939205A1 Tricyclic compound |
| 07/02/2008 | EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939202A1 Novel adenine compound |
| 07/02/2008 | EP1939201A1 Novel adenine compound |
| 07/02/2008 | EP1939200A1 Novel adenine compound |
| 07/02/2008 | EP1939199A1 Novel adenine compound |
| 07/02/2008 | EP1939198A1 Novel adenine compound |
| 07/02/2008 | EP1939189A1 Derivative having ppar agonistic activity |
| 07/02/2008 | EP1939175A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 07/02/2008 | EP1938838A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 07/02/2008 | EP1938837A1 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 07/02/2008 | EP1938827A1 Novel inhibitor of vascular endothelial growth factor expression |
| 07/02/2008 | EP1938823A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 07/02/2008 | EP1938819A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938818A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938811A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 07/02/2008 | EP1938810A1 Ameliorating agent for metabolic syndrome |
| 07/02/2008 | EP1937277A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 07/02/2008 | EP1937238A1 Novel nitrocatechol derivatives having selectin ligand activity |